ClinConnect ClinConnect Logo
Search / Trial NCT06839846

Survey of Different Modes of Weaning in Pediatric Population

Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Feb 17, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Weaning

ClinConnect Summary

This clinical trial, titled "Survey of Different Modes of Weaning in Pediatric Population," is studying how babies transition from a milk-only diet to eating a variety of foods. Weaning is an important step in a child's development, and there are different ways to do it. Some parents follow a traditional method, where they give specific foods at set times, while others let their child choose what and how much to eat during family meals. The goal of this study is to understand how common these different weaning methods are and what parents and pediatricians think about their advantages and disadvantages. The researchers will also look into any potential risks, like feeding mistakes or choking hazards that might happen during this transition.

To participate in the study, parents must have children between 4 and 18 months old, be fluent in Italian, and have access to the internet to complete a questionnaire. Pediatricians who work in Italy can also participate. Parents of children with certain medical conditions, like chronic diseases or swallowing difficulties, are not eligible. Participants can expect to share their experiences and opinions about weaning, contributing to valuable research that may help other families in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Parents group:
  • Overage parents with children between the ages of 4 and 18 months
  • Need to have an electronic tool that allows direct access to the link connected to an internet network
  • Understanding of the Italian language
  • Obtaining informed consent from the parent completing the questionnaire
  • Pediatricians group:
  • Activities of Free Choice Pediatrician in Italy.
  • Need to have an electronic tool that allows direct access to the link connected to an Internet network
  • Obtaining informed consent
  • Exclusion Criteria:
  • Parents group:
  • - Parents of children with chronic neurological diseases, dysphagia, chronic diseases involving specific diet, intestinal diseases resulting in malabsorption;
  • Pediatricians group:
  • - None

About Irccs Azienda Ospedaliero Universitaria Di Bologna

IRCCS Azienda Ospedaliero-Universitaria di Bologna is a prestigious research and healthcare institution in Italy, renowned for its commitment to advancing medical science and patient care through innovative clinical research. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it integrates clinical practice with scientific research, facilitating the translation of laboratory findings into effective treatment strategies. The institution fosters a multidisciplinary approach, collaborating with various experts to conduct high-quality clinical trials aimed at improving health outcomes across a wide range of medical fields. With a strong emphasis on ethical standards and patient welfare, IRCCS Azienda Ospedaliero-Universitaria di Bologna plays a vital role in shaping the future of medicine through rigorous scientific inquiry and patient-centered care.

Locations

Bologna, , Italy

Carpi, Modena, Italy

Imola, Bologna, Italy

Bologna, , Italy

Patients applied

0 patients applied

Trial Officials

Arianna Dondi, MD

Principal Investigator

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported